NCT04043455 · Interventional trial
Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)
Overall registry status Terminated
Phase 2
Conditions Irritable Bowel Syndrome
Delaware Valley sites
- Hassman Research Institute · Berlin, NJ · Camden County
First posted
Registry updated
Added to the directory